Antiparasitic immunotherapy combination

This page covers all Antiparasitic immunotherapy combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Leishmania cell membrane; GM-CSF receptor.

Targets

Leishmania cell membrane; GM-CSF receptor

Phase 3 pipeline (1)

• Miltefosine plus GM-CSF · Hospital Universitário Professor Edgard Santos · Infectious Disease / Parasitology
  Miltefosine combined with GM-CSF works by inducing immunogenic cell death and enhancing immune activation to treat leishmaniasis.

Patent intelligence

• antiparasitic immunotherapy combination patent landscape — aggregated cliff calendar, attackable patents, originator estates